196 related articles for article (PubMed ID: 4386485)
1. [Vasoneuroactive substance, antiaminic BC-105 and migraine].
Sicuteri F; Anselmi B; Del Bianco PL
Clin Ter; 1967 Jan; 40(2):117-28. PubMed ID: 4386485
[No Abstract] [Full Text] [Related]
2. [Therapy of vasomotor headache with a new drug: BC 105. Preliminary results].
Tedeschi G; Lettieri M; Turra MV
Acta Neurol (Napoli); 1971; 26(1):61-5. PubMed ID: 5573147
[No Abstract] [Full Text] [Related]
3. [Drug therapy of migraine and cluster headache].
Heyck H
Dtsch Med Wochenschr; 1975 Jun; 100(23):1293-6. PubMed ID: 237749
[No Abstract] [Full Text] [Related]
4. [Clinical experiences with polyantiaminic BC-105 Sandoz in the prevention of vasomotor headaches].
Sercl M; Vrcha L
Schweiz Rundsch Med Prax; 1970 May; 59(18):679-83. PubMed ID: 4396441
[No Abstract] [Full Text] [Related]
5. [Deseril (methysergide) in the treatment of vascular migraine headache].
Zec N; Bokonjić R
Neuropsihijatrija; 1964; 12(1-4):137-45. PubMed ID: 16305167
[No Abstract] [Full Text] [Related]
6. [Effects of a long-term administration on an antiserotonin agent, Lysenyl, in headaches of different origins].
Ripka O
Minerva Med; 1972 Sep; 63(60):3266-71. PubMed ID: 5054009
[No Abstract] [Full Text] [Related]
7. [Tests of BC 105 in 20 cases of vascular headache].
Olivares L; De la Peña F
Alergia; 1969 Nov; 17(2):67-73. PubMed ID: 4392873
[No Abstract] [Full Text] [Related]
8. Prophylactic treatment of cluster headache with a new serotonin antagonist, BC 105.
Ekbom K
Acta Neurol Scand; 1969; 45(5):601-10. PubMed ID: 4391566
[No Abstract] [Full Text] [Related]
9. Cyproheptadine (Peritol) in the treatment of migraine and related headache.
Klimek A
Ther Hung; 1979; 27(2):93-4. PubMed ID: 494146
[No Abstract] [Full Text] [Related]
10. The pathophysiology and treatment of migraine.
Lance JW
N Z Med J; 1974 May; 79(515):954-60. PubMed ID: 4153136
[No Abstract] [Full Text] [Related]
11. [Clinical observations on Sandomigren in treatment of headaches].
Stein W
Neurol Neurochir Pol; 1974; 8(2):213-4. PubMed ID: 4150967
[No Abstract] [Full Text] [Related]
12. [Contribution of Nocretone to the treatment of migraine and headache].
Warot P; Petit H; Lehembre P
Lille Med; 1976 Jan; 21(1 suppl 1):20-3. PubMed ID: 1256228
[No Abstract] [Full Text] [Related]
13. [Propranolol in the treatment of migraine and similar headaches].
Klimek A; Niewodniczy A; Poźniak-Patewicz E; Rydzewski W
Pol Tyg Lek; 1978 Jul; 33(28):1109-11. PubMed ID: 704408
[No Abstract] [Full Text] [Related]
14. [Migraine--vasomotor headache and its therapeutic approaches].
Glaser A
Med Welt; 1974 Sep; 25(36):1435-8. PubMed ID: 4612289
[No Abstract] [Full Text] [Related]
15. Trial of a serotonin inhibitor BC 105 in the prevention of migraine.
Hornabrook RW; Arthur G
N Z Med J; 1969 Dec; 70(451):387-90. PubMed ID: 4392184
[No Abstract] [Full Text] [Related]
16. [Prevention of migraine. Observations on the possibilities offered by some polypeptides].
Nattero G; Lisino F; Brandi G; Agostoni A; Cottino A
Minerva Med; 1976 Nov; 67(54):3533-8. PubMed ID: 995301
[TBL] [Abstract][Full Text] [Related]
17. [Use of cyproheptadine in the treatment of headaches].
Klimek A
Wiad Lek; 1974 Oct; 27(19):1713-6. PubMed ID: 4417196
[No Abstract] [Full Text] [Related]
18. [Sandomigran (BC-105) in treatment of migraine and Horton's headache].
Prusiński A; Kotwica S; Rydzewski W; Zawadzki Z
Neurol Neurochir Pol; 1972; 6(3):427-31. PubMed ID: 5032295
[No Abstract] [Full Text] [Related]
19. Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches.
Speight TM; Avery GS
Drugs; 1972; 3(3):159-203. PubMed ID: 4403890
[No Abstract] [Full Text] [Related]
20. Comparison of No-Spa and vasalgin for the treatment of headaches associated with vasomotor and cerebral disorders.
Máttyus A
Ther Hung; 1968; 16(2):71-4. PubMed ID: 5666417
[No Abstract] [Full Text] [Related]
[Next] [New Search]
